Evidence map›Paper›PMID 38333213›Full record

ArticleFrontiers in immunology2024

Characterizing Foxp3

Zilei Liu, Katherine J Baines, Natalie M Niessen, Munish K Heer, David Clark, G Alexander Bishop, Paul R Trevillian

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zilei LiuTransplant Unit, John Hunter Hospital, Newcastle, NSW, Australia.
Katherine J BainesTransplant and Surgical Immunology Theme, Immune Health Research Program, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia.
Natalie M NiessenTransplant and Surgical Immunology Theme, Immune Health Research Program, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia.
Munish K HeerTransplant Unit, John Hunter Hospital, Newcastle, NSW, Australia.
David ClarkTransplant Unit, John Hunter Hospital, Newcastle, NSW, Australia.
G Alexander BishopTransplantation Immunobiology Group, University of Sydney Central Clinical School, Charles Perkins Centre, Faculty of Medicine and Health, Sydney, NSW, Australia.
Paul R TrevillianTransplant Unit, John Hunter Hospital, Newcastle, NSW, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to the intracellular expression of Foxp3 it is impossible to purify viable Foxp3

Indexed as

Forkhead Transcription FactorsProgrammed Cell Death 1 ReceptorT-Lymphocytes, RegulatoryAnimalsCTLA-4 AntigenFlow CytometryKi-67 AntigenMiceCTLA-4 AntigenForkhead Transcription FactorsFoxp3 protein, mouseKi-67 AntigenProgrammed Cell Death 1 ReceptorCTLA-4differential gene expressionFoxp3PD-1regulatory T cellsT cell proliferation

Identifiers

PMID38333213
PMCPMC10850883

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.